These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15527809)

  • 1. Surveillance of patients at high risk for colorectal cancer.
    Syngal S; Bandipalliam P; Boland CR
    Med Clin North Am; 2005 Jan; 89(1):61-84, vii-viii. PubMed ID: 15527809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
    Konda A; Duffy MC
    Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of high-risk colonoscopy patients.
    Bresalier RS
    Gastrointest Endosc Clin N Am; 2010 Oct; 20(4):629-40. PubMed ID: 20889068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and surveillance of colorectal cancer.
    Kahi CJ; Rex DK
    Gastrointest Endosc Clin N Am; 2005 Jul; 15(3):533-47, ix. PubMed ID: 15990056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer: screening and surveillance for high-risk individuals.
    Ferrández A; DiSario JA
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):851-62. PubMed ID: 14686707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Vleggaar FP; Lutgens MW; Claessen MM
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening and surveillance.
    Harford WV
    Surg Oncol Clin N Am; 2006 Jan; 15(1):1-20, v. PubMed ID: 16389147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
    Levin B; Lieberman DA; McFarland B; Andrews KS; Brooks D; Bond J; Dash C; Giardiello FM; Glick S; Johnson D; Johnson CD; Levin TR; Pickhardt PJ; Rex DK; Smith RA; Thorson A; Winawer SJ; ; ;
    Gastroenterology; 2008 May; 134(5):1570-95. PubMed ID: 18384785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
    Shaw C; Cunningham R; Sarfati D
    N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malpractice risks associated with colon cancer and inflammatory bowel disease.
    Feld AD
    Am J Gastroenterol; 2004 Sep; 99(9):1641-4. PubMed ID: 15330895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of epidemiology for screening and early detection of cancer: examples from Austria.
    Ulsperger E; Hofbauer F
    Neoplasma; 1992; 39(3):185-8. PubMed ID: 1528324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in young patients with poor health and severe comorbidity.
    Sultan S; Conway J; Edelman D; Dudley T; Provenzale D
    Arch Intern Med; 2006 Nov; 166(20):2209-14. PubMed ID: 17101938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with a general population colorectal cancer screening clinic.
    Brosseuk D; Oosthuizen J; Pinchbeck M
    Am J Surg; 2006 May; 191(5):669-72. PubMed ID: 16647357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening and surveillance: current standards and future trends.
    Martinez SR; Young SE; Hoedema RE; Foshag LJ; Bilchik AJ
    Ann Surg Oncol; 2006 Jun; 13(6):768-75. PubMed ID: 16604473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.